Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome
Más información
Título según WOS: | Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome |
Título según SCOPUS: | Resistance of leukemia cells to cytarabine chemotherapy is mediated by bone marrow stroma, involves cell-surface equilibrative nucleoside transporter-1 removal and correlates with patient outcome |
Título de la Revista: | ONCOTARGET |
Volumen: | 8 |
Número: | 14 |
Editorial: | IMPACT JOURNALS LLC |
Fecha de publicación: | 2017 |
Página de inicio: | 23073 |
Página final: | 23086 |
Idioma: | English |
DOI: |
10.18632/oncotarget.14981 |
Notas: | ISI, SCOPUS |